Paper42432829
Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.
Man SK and 7 others. Eur J Neurosci, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia. Papers, record 42432829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42432829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glutamic Acid | Major topic |
| Schizophrenia | Major topic |
| Psychotic Disorders | Major topic |
| Brain | Major topic |
| Humans | |
| Male | |
| Female | |
| Adult | |
| Young Adult | |
| Proton Magnetic Resonance Spectroscopy | |
| Hippocampus | |
| Adolescent |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 260879 | Canada Foundation for Innovation | PubMed | ||
| 254592 | Healthy Brains, Healthy Lives | PubMed | ||
| Healthy Brains, Healthy Lives (HBHL) | PubMed | |||
| Canada Foundation for Innovation's (CFI) | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28503156 | Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies. | Front Psychiatry | 2017 | https://conductscience.org/library/papers/28503156 | PubMed |
| 2 | 26117693 | Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. | Magn Reson Imaging | 2015 | https://conductscience.org/library/papers/26117693 | PubMed |
| 3 | 16018980 | Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. | Biol Psychiatry | 2005 | https://conductscience.org/library/papers/16018980 | PubMed |
| 4 | 3616518 | The positive and negative syndrome scale (PANSS) for schizophrenia. | Schizophr Bull | 1987 | https://conductscience.org/library/papers/3616518 | PubMed |
| 5 | 9355168 | The MacCAT-T: a clinical tool to assess patients' capacities to make treatment decisions. | Psychiatr Serv | 1997 | https://conductscience.org/library/papers/9355168 | PubMed |
| 6 | 29031411 | In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T. | Biol Psychiatry | 2018 | https://conductscience.org/library/papers/29031411 | PubMed |
| 7 | 36806762 | Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/36806762 | PubMed |
| 8 | 26925800 | Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla. | Schizophr Res | 2016 | https://conductscience.org/library/papers/26925800 | PubMed |
| 9 | 34584230 | Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/34584230 | PubMed |
| 10 | 12955285 | NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. | Psychopharmacology (Berl) | 2003 | https://conductscience.org/library/papers/12955285 | PubMed |
| 11 | 34505389 | Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls. | World Psychiatry | 2021 | https://conductscience.org/library/papers/34505389 | PubMed |
| 12 | 14989408 | Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. | Schizophr Bull | 2003 | https://conductscience.org/library/papers/14989408 | PubMed |
| 13 | 26320195 | Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction. | Schizophr Bull | 2016 | https://conductscience.org/library/papers/26320195 | PubMed |
| 14 | 42432829 | Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia. | Eur J Neurosci | 2026 | https://conductscience.org/library/papers/42432829 | PubMed |
| 15 | 30427993 | Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis. | JAMA Psychiatry | 2019 | https://conductscience.org/library/papers/30427993 | PubMed |
| 16 | 32303767 | Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study. | Schizophr Bull | 2020 | https://conductscience.org/library/papers/32303767 | PubMed |
| 17 | 34259821 | Probability of Transition to Psychosis in Individuals at Clinical High Risk: An Updated Meta-analysis. | JAMA Psychiatry | 2021 | https://conductscience.org/library/papers/34259821 | PubMed |
| 18 | 21956446 | From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. | Neuropsychopharmacology | 2012 | https://conductscience.org/library/papers/21956446 | PubMed |
| 19 | 25548816 | Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. | J Magn Reson Imaging | 2014 | https://conductscience.org/library/papers/25548816 | PubMed |
| 20 | 35396580 | Mapping genomic loci implicates genes and synaptic biology in schizophrenia. | Nature | 2022 | https://conductscience.org/library/papers/35396580 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42432829 | Group Differences of Multiregion Glutamate Concentration in Clinical High Risk and Schizophrenia. | Eur J Neurosci | 2026 | https://conductscience.org/library/papers/42432829 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42432829
GET https://conductscience.org/api/papers/v1/42432829/references?page=2